This inventor holds 1 USPTO granted patent. Top assignee: Molecure S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jacek Olczak: Innovator in Arginase Inhibition
Introduction
Jacek Olczak is a notable inventor based in Lodz, Poland. He has made significant contributions to the field of therapeutics, particularly in the development of compounds that inhibit arginase activity. His work is crucial for advancing treatments for diseases associated with arginase.
Latest Patents
Jacek Olczak holds a patent for "Arginase inhibitors and methods of use thereof." This inventive compound is a small molecule therapeutic that serves as a potent inhibitor of arginase 1 and arginase 2 activity. The invention also encompasses pharmaceutical compositions that include these compounds, along with methods for utilizing them to treat or prevent diseases linked to arginase activity. He has 1 patent to his name.
Career Highlights
Jacek Olczak is currently associated with Molecure S.A., where he continues to innovate in the field of biopharmaceuticals. His expertise in arginase inhibitors positions him as a key player in therapeutic development.
Collaborations
Some of his notable coworkers include Anna Gzik and Jacek Chrzanowski, who contribute to the collaborative environment at Molecure S.A. Their combined efforts enhance the research and development initiatives within the company.
Conclusion
Jacek Olczak's work in arginase inhibition represents a significant advancement in therapeutic innovation. His contributions are vital for the ongoing development of treatments for conditions related to arginase activity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile